α-Lipoic acid - The potential for use in cancer therapy Minireview

Neoplasma

Volumn 55, Issue 2, 2008, Pages 81-86

  Novotny, L ^a   Rauko, P ^b   Cojocel, C ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

^b INSTITUTE OF CHEMISTRY   (Slovakia)

Author keywords

Biological activity; Cancer prevention; Cancer therapy; Lipoic acid; Mechanism of action

Indexed keywords

ACETYLCYSTEINE; CALCITRIOL; COLECALCIFEROL; CYCLOPHOSPHAMIDE; DIHYDROLIPOATE; DOXORUBICIN; MEDROXYPROGESTERONE ACETATE; NALTREXONE; OXALIPLATIN; PROTEIN BCL 2; PYRUVATE DEHYDROGENASE; PYRUVATE DEHYDROGENASE COMPLEX; RECOMBINANT INTERLEUKIN 2; THIOCTIC ACID; TUMOR NECROSIS FACTOR ALPHA; SCAVENGER;

ANTIOXIDANT ACTIVITY; APOPTOSIS; BIOLOGICAL ACTIVITY; CANCER CELL; CANCER CHEMOTHERAPY; CARDIOMYOPATHY; CARDIOTOXICITY; CELL GROWTH; CELL VIABILITY; CLINICAL TRIAL; COLON CANCER; CYTOTOXICITY; DNA FRAGMENTATION; DOWN REGULATION; DRUG INHIBITION; DRUG MECHANISM; DRUG POTENTIATION; DRUG PROTEIN BINDING; DRUG STRUCTURE; DRUG TARGETING; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME MECHANISM; GLUCOSE BLOOD LEVEL; GLUTATHIONE METABOLISM; HUMAN; HYPERLIPIDEMIA; IN VITRO STUDY; IN VIVO STUDY; LEUKEMIA; NEPHROTOXICITY; NONHUMAN; PANCREAS CANCER; POLYNEUROPATHY; PRIMARY TUMOR; SHORT SURVEY; SINGLE DRUG DOSE; ANIMAL; NEOPLASM; REVIEW;

ANIMALS; FREE RADICAL SCAVENGERS; HUMANS; NEOPLASMS; THIOCTIC ACID;

EID: 48549085904     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (50)

1. DOVINOVA I. α-Lipoic acid - natural disulfidic cofactor and antioxidant with anticarcinogenic activities. Cs Farmacie 1996; 45: 237-241 (In Slovak).
2. PERHAM RN. Swinging arms and swinging domains in multifunctional enzymes: catalytic machines for multistep reactions. Ann Rev Biochem 2000; 69: 961-1004.
3. REED LJ, DEBUSK BG, GUNSALUS IC, et al. Crystalline alpha-lipoic acid; a catalytic agent associated with pyruvate dehydrogenase. Science 1951; 114:93-94.
4. MILNE JL, WU X, BORGNIA MJ, et al, Molecular structure of a 9-MDa icosahedral pyruvate dehydrogenase subcomplex containing the E2 and E3 enzymes using cryoelectron microscopy. J Biol Chem 2006; 281: 4364-4370.
5. FUJIWARA K, OKAMURA-IKEDA K, MOTOKAWA Y. Chicken liver H-protein, a component of the glycine cleavage system. Amino acid sequence and identification of the N epsilon-lipoyllysine residue. J Biol Chem 1986; 261: 8836-8841.
6. VANDEN BOOM TJ, REED KE, CRONAN JE JR. Lipoic acid metabolism in Escherichia coli: isolation of null mutants defective in lipoic acid biosynthesis, molecular cloning and characterization of the E. coli lip locus, and identification of the lipoylated protein of the glycine cleavage system. J Bacteriol 1991; 173: 6411-6420.
7. PEINADO J, SIES H, AKERBOOM TP. Hepatic lipoate uptake. Arch Biochem Biophys 1989; 173: 389-395.
8. KAGAN VE, SHVEDOVA A. Dihydrolipoic acid- a universal antioxidant both in the membrane and in the aqueous phase. Reduction of peroxyl, ascorbyl and chromanoxyl radicals. Biochem Pharmacol 1992; 44: 1637-1649.
9. PACKER L, WITT EH, TRITSCHLER HJ. alpha-Lipoic acid as a biological antioxidant. Free Radic Biol Med 1995; 19: 227-250.
10. SMITH JR, THIAGARAJ HV, SEAVER B, et al.. Differential activity of lipoic acid enantiomers in cell culture. J Herb Pharmacother 2005; 5: 43-54.
11. KAGAN VE, SHVEDOVA A, SERBINOVA E, et al. Dihydrolipoic acid - universal antioxidant both in the membrane and in the aqueous phase. Reduction of peroxyl, ascorbyl and chromanoxyl radicals. Biochem Pharmacol 1992; 44: 1637-1649.
12. HENRIKSEN EJ. Exercise training and the antioxidant alpha-lipoic acid in the treatment of insulin resistance and type 2 diabetes. Free Radic Biol Med 2006; 40: 3-12.
13. LYKKESFELDT J, HAGEN TM, VINARSKY V, et al. Age-associated decline in ascorbic acid concentration, recycling, and biosynthesis in rat hepatocytes - reversal with (R)-alpha-lipoic acid supplementation. FASEB J 1998; 12: 1183-1189.
14. SCHOLICH H, MURPHY ME, SIES H. Antioxidant activity of dihydrolipoate against microsomal lipid peroxidation and its dependence on alpha-tocopherol. Biochem Biophys Acta 1989; 1001: 256-261. (Pubitemid 19051280)
15. BUSSE E, ZIMMER G, SCHORPOHL B, et al.. Influence of alpha-lipoic acid on intracellular glutathione in vitro and in vivo. Arzneimittelforschung 1992; 42: 829-831.
16. KAGAN V, SERBINOVA E, PACKER L. Antioxidant effects of ubiquinones in microsomes and mitochondria are mediated by tocopherol recycling. Biochem Biophys Res Commun 1990; 169: 851-857.
17. CREMER DR, RABELER R, ROBERTS A, et al. Safety evaluation of alpha-lipoic acid (ALA). Regul Toxicol Pharmacol 2006; 46: 29-41.
18. MIADOKOVA E, VLCKOVA V, DUHOVA V. Antimutagenic effect of alpha-lipoic acid on three model test systems. Pharmazie 2000; 55: 862-863.
19. JORDAN SW, CRONAN JE JR. A new metabolic link. The acyl carrier protein of lipid synthesis donates lipoic acid to the pyruvate dehydrogenase complex in Escherichia coli and mitochondria. J Biol Chem 1997; 272: 17903-17906.
20. REED LJ, KOIKE M, LEVITCH ME, et al. Studies on the nature and reactions of protein-bound lipoic acid. J Biol Chem 1958; 232: 143-158.
21. JIANG Y, CRONAN JE. Expression cloning and demonstration of Enterococcus faecalis lipoamidase (pyruvate dehydrogenase inactivase) as a Ser-Ser-Lys triad amidohydrolase. J Biol Chem 2005; 280: 2244-2256.
22. KOROTCHKINA LG, SIDHU S, PATEL MS. R-lipoic acid inhibits mammalian pyruvate dehydrogenase kinase. Free Radic Res 2004; 38: 1083-1092.
23. MCMANUS E, LUISI BF, PERHAM RN. Structure of a putative lipoate protein ligase from Thermoplasma acidophilum and the mechanism of target selection for post-translational modification. J Mol Biol 2006; 356: 625-637.
24. STOYANOVSKY DA, TYURINA YY, TYURIN VA, et al. Thioredoxin and lipoic acid catalyze the denitrosation of low molecular weight and protein S-nitrosothiols. J Am Chem Soc 2005; 127: 15815-15823.
25. WENZEL U, NICKEL A, DANIEL H. alpha-Lipoic acid induces apoptosis in human colon cancer cells by increasing mitochondrial respiration with a concomitant O2-*-generation. Apoptosis 2005; 10: 359-368.
26. MYZAK MC, CARR AC. Myeloperoxidase-dependent caspase-3 activation and apoptosis in HL-60 cells: protection by the antioxidants ascorbate and (dihydro)lipoic acid. Redox Rep 2002; 7: 47-53.
27. SEN CK, ROY S, HAN D, PACKER L. Regulation of cellular thiols in human lymphocytes by alpha-lipoic acid: a flow cytometric analysis. Free Radic Biol Med 1997; 22: 1241-1257.
28. HAN D, HANDELMAN G, MARCOCCI L, et al. Lipoic acid increases de novo synthesis of cellular glutathione by improving cystine utilization. Biofactors 1997; 6: 321-338.
29. SOKOLOSKI JA, HODNICK WF, MAYNE ST, et al. Induction of the differentiation of HL-60 promyelocytic leukemia cells by vitamin E and other antioxidants in combination with low levels of vitamin D3: possible relationship to NF-kappaB. Leukemia 1997; 11: 1546-1553.
30. WEITSMAN GE, RAVID A, LIBERMAN UA, et al. Vitamin D enhances caspase-dependent and -independent TNFalpha-induced breast cancer cell death: The role of reactive oxygen species and mitochondria. Int J Cancer 2003; 106: 178-186. (Pubitemid 36835169)
31. WEITSMAN GE, RAVID A, LIBERMAN UA, et al. Vitamin D enhances caspase-dependent and independent TNF-induced breast cancer cell death: the role of reactive oxygen species. Ann NY Acad Sci 2003; 1010: 437-440. (Pubitemid 38265021)
32. VAN DE MARK K, CHEN JS, STELIOU K, et al. Alphalipoic acid induces p27Kip-dependent cell cycle arrest in non-transformed cell lines and apoptosis in tumor cell lines. J Cell Physiol 2003; 194: 325-340. (Pubitemid 36181524)
33. FLIER J, VAN MUISWINKEL FL, JONGENELEN CA, et al. The neuroprotective antioxidant alpha-lipoic acid induces detoxication enzymes in cultured astroglial cells. Free Radic Res 2002; 36: 695-699.
34. PACK RA, HARDY K, MADIGAN MC, et al. Differential effects of the antioxidant alpha-lipoic acid on the proliferation of mitogen-stimulated peripheral blood lymphocytes and leukaemic T cells. Mol Immunol 2002; 38: 733-745.
35. MANTOVANI G, MACCIO A, MELIS G, et al.. Restoration of functional defects in peripheral blood mononuclear cells isolated from cancer patients by thiol antioxidants alpha-lipoic acid and N-acetyl cysteine. Int J Cancer 2000; 86: 842-847.
36. MOUNGJAROEN J, NIMMANNIT U, CALLERY PS, et al. Reactive oxygen species mediate caspase activation and apoptosis induced by lipoic acid in human lung epithelial cancer cells through Bcl-2 down-regulation. J Pharmacol Exp Ther 2006; 319: 1062-1069.
37. DOVINOVA I, NOVOTNY L, RAUKO P, et al. Combined effect of lipoic acid and doxorubicin in murine leukemia. Neoplasma 1999; 46: 237-241.
38. BERKSON BM, RUBIN DM, BERKSON AJ. The long-term survival of a patient with pancreatic cancer with metastases to the liver after treatment with the intravenous alpha-lipoic acid/low-dose naltrexone protocol. Integr Cancer Ther 2006; 5: 83-89.
39. MYTHILI Y, SUDHARSAN PT, SUDHAHAR V, et al. Protective effect of DL-alpha-lipoic acid on cyclophosphamide induced hyperlipidemic cardiomyopathy. Eur J Pharmacol 2006; 543: 92-96. (Pubitemid 44092703)
40. MYTHILI Y, SUDHARSAN PT, AMUDHA G, et al.Effect of dl-alpha-lipoic acid on cyclophosphamide induced lysosomal changes in oxidative cardiotoxicity. Life Sci 2007; 80: 1993-1998.
41. MALARKODI KP, BALACHANDAR AV, VARALAKSHMI P. The influence of lipoic acid on adriamycin induced nephrotoxicity in rats. Mol Cell Biochem. 2003; 247: 15-22. (Pubitemid 36798504)
42. MALARKODI KP, BALACHANDAR AV, VARLAKSHMI P. The influence of lipoic acid on adriamycin-induced hyperlipidemic nephrotoxicity in rats. Mol Cell Biochem 2003; 247: 139-145. (Pubitemid 36798518)
43. MALARKODI KP, BALACHANDAR AV, VARALAKSHMI P. Protective effect of lipoic acid on adriamycin-induced lipid peroxidation in rat kidney. Mol Cell Biochem 2003; 247: 9-13. (Pubitemid 36798503)
44. MALARKODI KP, BALACHANDAR AV, SIVAPRASAD R, et al. Prophylactic effect of lipoic acid against adriamycininduced peroxidative damages in rat kidney. Ren Fail 2003; 25: 367-377.
45. BALACHANDAR AV, MALARKODI KP, VARALAKSHMI P. Protective role of DLalpha-lipoic acid against adriamycin-induced cardiac lipid peroxidation. Hum Exp Toxicol 2003; 22: 249-254.
46. AL-MAJED AA, GDO AM, AL-SHABANAH OA, et al.Alpha-lipoic acid ameliorates myocardial toxicity induced by doxorubicin. Pharmacol Res 2002; 46: 499-503.
47. BEDLIKE C, SCHEITHAUER W, SCHULL B et al. Effective treatment of oxaliplatin-induced cumulative polyneuropathy with alpha-lipoic acid. J Clin Oncol 2002; 20: 3359-3361.
48. HAN D, SEN CK, ROY S, et al.. Protection against glutamateinduced cytotoxicity in C6 glial cells by thiol antioxidants. Am J Physiol 1997; 273: R1771-1778.
49. MANTOVANI G, MACCIO A, MADEDDU C, et al.Phase II study of subcutaneously administered interleukin-2 in combination with medroxyprogesterone acetate and antioxidant agents as maintenance treatment in advanced cancer responders to previous chemotherapy. Oncol Rep 2002; 9: 887-896.
50. MANTOVANI G, MADEDDU C, GRAMIGNANO G, et al. Subcutaneous interleukin-2 in combination with medroxyprogesterone acetate and antioxidants in advanced cancer responders to previous chemotherapy: phase II study evaluating clinical, quality of life, and laboratory parameters. J Exp Ther Oncol 2003; 3: 205-219.